ARTICLE | Clinical News
Atu134: Development discontinued
November 14, 2011 8:00 AM UTC
Silence discontinued development of preclinical candidate Atu134 after concluding its potential clinical profile is too similar to Atu027 to warrant development of both compounds. Atu027, a liposomal...